FDA Warning Letter — Abbott's Compounding Pharmacy, Inc.
The FDA took a Warning Letter action against Abbott's Compounding Pharmacy, Inc. on Apr 4, 2017 (Berkeley, CA). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Abbott's Compounding Pharmacy, Inc.
- Date
- Apr 4, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Berkeley, CA (United States)